Skip to content
Catalyst

psilocybinPapers

Papers about psilocybin

papers
210
25 years, by papers

Newest first

151 to 200 of 210

Every paper here, unless its row says otherwiseIndexed under psilocybin in PubMed's chemical list; returned by a PubMed search for psilocybin

  • Dose-response relationships of psilocybin-induced subjective experiences in humans.

    Journal of psychopharmacology (Oxford, England)2021PMID 33663259Also indexed under psilocybin as a PubMed major topic

  • Spontaneous and deliberate creative cognition during and after psilocybin exposure.

    Translational psychiatry2021PMID 33833225Also indexed under psilocybin as a PubMed major topic

  • Trial of Psilocybin versus Escitalopram for Depression.

    The New England journal of medicine2021PMID 33852780Indexed under psilocybin in PubMed's chemical list

  • Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer.

    Journal of psychopharmacology (Oxford, England)2020PMID 31916890

  • The experimental effects of psilocybin on symptoms of anxiety and depression: A meta-analysis.

    Psychiatry research2020PMID 31931272

  • Emotions and brain function are altered up to one month after a single high dose of psilocybin.

    Scientific reports2020PMID 32042038

  • Psilocybin Induces Time-Dependent Changes in Global Functional Connectivity.

    Biological psychiatry2020PMID 32111343Also indexed under psilocybin as a PubMed major topic

  • Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybin.

    Neuropsychopharmacology2020PMID 32446245Also indexed under psilocybin as a PubMed major topic

  • Subjective features of the psilocybin experience that may account for its self-administration by humans: a double-blind comparison of psilocybin and dextromethorphan.

    Psychopharmacology2020PMID 32500212Also indexed under psilocybin as a PubMed major topic

  • P300-mediated modulations in self-other processing under psychedelic psilocybin are related to connectedness and changed meaning: A window into the self-other overlap.

    Human brain mapping2020PMID 32820851

  • Psilocybin-assisted mindfulness training modulates self-consciousness and brain default mode network connectivity with lasting effects.

    NeuroImage2019PMID 30965131

  • Replication and extension of a model predicting response to psilocybin.

    Psychopharmacology2019PMID 31203401

  • Characterization and prediction of acute and sustained response to psychedelic psilocybin in a mindfulness group retreat.

    Scientific reports2019PMID 31649304

  • Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors.

    Journal of psychopharmacology (Oxford, England)2018PMID 29020861

  • Psilocybin with psychological support improves emotional face recognition in treatment-resistant depression.

    Psychopharmacology2018PMID 29085980

  • Psilocybin with psychological support for treatment-resistant depression: six-month follow-up.

    Psychopharmacology2018PMID 29119217

  • Increased nature relatedness and decreased authoritarian political views after psilocybin for treatment-resistant depression.

    Journal of psychopharmacology (Oxford, England)2018PMID 29338538

  • Natural speech algorithm applied to baseline interview data can predict which patients will respond to psilocybin for treatment-resistant depression.

    Journal of affective disorders2018PMID 29407543

  • Lysergic acid diethylamide and psilocybin for the management of patients with persistent pain: a potential role?

    Pain management2018PMID 29722608

  • Psilocybin and MDMA reduce costly punishment in the Ultimatum Game.

    Scientific reports2018PMID 29844496

  • Effects of psilocybin therapy on personality structure.

    Acta psychiatrica Scandinavica2018PMID 29923178

  • High dose psilocybin is associated with positive subjective effects in healthy volunteers.

    Journal of psychopharmacology (Oxford, England)2018PMID 29945469

  • Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: effects on cognition.

    Psychopharmacology2018PMID 30062577

  • Does getting high hurt? Characterization of cases of LSD and psilocybin-containing mushroom exposures to national poison centers between 2000 and 2016.

    Journal of psychopharmacology (Oxford, England)2018PMID 30182795

  • Long-term follow-up of psilocybin-facilitated smoking cessation.

    The American journal of drug and alcohol abuse2017PMID 27441452

  • Effect of Psilocybin on Empathy and Moral Decision-Making.

    The international journal of neuropsychopharmacology2017PMID 28637246

  • Two dose investigation of the 5-HT-agonist psilocybin on relative and global cerebral blood flow.

    NeuroImage2017PMID 28711736

  • Modulatory effect of the 5-HT1A agonist buspirone and the mixed non-hallucinogenic 5-HT1A/2A agonist ergotamine on psilocybin-induced psychedelic experience.

    European neuropsychopharmacology2016PMID 26875114

  • Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial.

    Journal of psychopharmacology (Oxford, England)2016PMID 27909164

  • Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial.

    Journal of psychopharmacology (Oxford, England)2016PMID 27909165

  • Psilocybin-Induced Decrease in Amygdala Reactivity Correlates with Enhanced Positive Mood in Healthy Volunteers.

    Biological psychiatry2015PMID 24882567

  • Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study.

    Journal of psychopharmacology (Oxford, England)2015PMID 25586396

  • Psilocybin-induced spiritual experiences and insightfulness are associated with synchronization of neuronal oscillations.

    Psychopharmacology2015PMID 26231498

  • Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin.

    Journal of psychopharmacology (Oxford, England)2015PMID 26442957

  • Spatiotemporal brain dynamics of emotional face processing modulations induced by the serotonin 1A/2A receptor agonist psilocybin.

    Cerebral cortex (New York, N.Y.2014PMID 23861318

  • Psilocybin-occasioned mystical experiences in the treatment of tobacco addiction.

    Current drug abuse reviews2014PMID 25563443

  • Activation of serotonin 2A receptors underlies the psilocybin-induced effects on α oscillations, N170 visual-evoked potentials, and visual hallucinations.

    The Journal of neuroscience2013PMID 23785166

  • Peak experiences of psilocybin users and non-users.

    Journal of psychoactive drugs2013PMID 23909006

  • Psilocybin-induced deficits in automatic and controlled inhibition are attenuated by ketanserin in healthy human volunteers.

    Neuropsychopharmacology2012PMID 21956447

  • Psilocybin dose-dependently causes delayed, transient headaches in healthy volunteers.

    Drug and alcohol dependence2012PMID 22129843

  • Implications for psychedelic-assisted psychotherapy: functional magnetic resonance imaging study with psilocybin.

    The British journal of psychiatry2012PMID 22282432

  • Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin.

    Proceedings of the National Academy of Sciences of the United States of America2012PMID 22308440

  • Prediction of psilocybin response in healthy volunteers.

    PloS one2012PMID 22363492

  • Psilocybin biases facial recognition, goal-directed behavior, and mood state toward positive relative to negative emotions through different serotonergic subreceptors.

    Biological psychiatry2012PMID 22578254

  • The administration of psilocybin to healthy, hallucinogen-experienced volunteers in a mock-functional magnetic resonance imaging environment: a preliminary investigation of tolerability.

    Journal of psychopharmacology (Oxford, England)2011PMID 20395317

  • Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer.

    Archives of general psychiatry2011PMID 20819978

  • Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies.

    Journal of psychopharmacology (Oxford, England)2011PMID 20855349

  • Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects.

    Psychopharmacology2011PMID 21674151

  • Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness.

    Journal of psychopharmacology (Oxford, England)2011PMID 21956378

  • Psychometric evaluation of the altered states of consciousness rating scale (OAV).

    PloS one2010PMID 20824211

The next 10 papers

← Previous 50